Pharmaron Beijing Co., Ltd. has intentions to construct a facility in the Hangzhou Bay New Area with a total estimated investment amount of RMB 3.5 billion (the "Potential Construction"). It is currently expected that the facility will be used for research and development services for discovery, development and manufacturing of biologics. The Company will implement the construction plan step-by-step.